Developmental regulation of expression of the α1 and α2 subunits mRNAs of the voltage-dependent calcium channel in a differentiating myogenic cell line  by Varadi, Gyula et al.
Volume 250, number 2, 515-518 FEB 07321 July 1989 
Developmental regulation of expression of the and subunits 
mRNAs of the voltage-dependent calcium channel in a 
differentiating myogenic ell line 
Gyula  Varadi,  John Orlowski* and Arnold  Schwartz 
Department ofPharmacology and Cell Biophysics and *Department of Molecular Genetics, Biochemistry and 
Microbiology, University of Cincinnati College ofMedicine, 231 Bethesda Avenue, Cincinnati, OH 45267-0575, USA 
Received 10 May 1989 
The voltage-dependent calcium channel (VDCC) inskeletal muscle probably plays a key role in transducing membrane 
charge movement to the calcium release channel. We report here that the expression fVDCC al and 0q mRNAs is devel- 
opmentally regulated in differentiating C2Ci2 myogenic cells. The a 1 mRNA isnot detectable in the myoblast form of 
C2C12 cells while its expression is induced 20-fold in differentiated myotubes. In contrast, he cq mRNA is weakly ex- 
pressed inmyoblasts but is also induced upon myogenic differentiation. 
Ca z÷ channel, voltage-dependent; mRNA; Developmental expression; Subunit, ~; Subunit, ~q; (C2C 12 myogenic cell) 
1. INTRODUCTION 
The induction of cellular processes leading to 
myoblast differentiation is closely coupled to 
cessation of cell division [1]. The deprivation of 
serum mitogens such as PDGF, EGF, FGF or 
TGF-/5' [2,3] is a prerequisite for the terminal com- 
mitment. The differentiation process is well- 
characterized by the deregulation of myoblast type 
gene products, such as/~-, 7-actin [2] and con- 
comitantly by induction of muscle-specific genes 
(te-actin, ACh receptor, creatine kinase, Na,K- 
ATPase re2 isoform [5] and components of the con- 
tractile apparatus (for review see [4]). 
There is considerable vidence that excitation- 
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contraction coupling in skeletal muscle T-tubule 
membranes, requires activation of a specific L- 
type voltage-dependent calcium channel (VDCC), 
which has been called a 'dihydropyridine r ceptor' 
[6-9]. The VDCC consists of a large 165 kDa 
subunit c~1, which contains the receptors for the 
calcium antagonists, a glycoprotein of about 
150 kDa, tr2 and several smaller subunits [21]. Rios 
et al. [6] have demonstrated that depolarization of 
the T-tubule is converted into intramembrane 
charge movements by the VDCC, a'l subunit which 
probably undergoes voltage-driven conforma- 
tional changes that in turn causes calcium release 
channels to pen. This sequence of events is also 
consistent with the absence of excitation-contrac- 
tion coupling in skeletal muscle of dysgenic mice 
[10,11]. This developmental bnormality is asso- 
ciated with diminished expression of the al  subunit 
of the VDCC and an altered coupling between T- 
tubules and sarcoplasmic reticulum [12]. This 
defect can be reversed either by coculturing with 
spinal cord cells, which leads to formation of nor- 
mal T-tubule and sarcoplasmic reticulum coupling 
[12], or by microinjecting these cells with an ex- 
pression plasmid encoding the a~l subunit [13]. 
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These observations taken together, clearly prove 
the essential role of the LYI subunit of the VDCC in 
the excitation-contraction coupling of skeletal 
muscle and suggest that expression of this protein 
complex may be developmentally regulated in the 
muscle-differentiation process. This paper shows 
that differentiating murine C2Cl2 myogenic cells 
express mRNAs for LYI and cry subunits of the 
voltage-gated calcium channel in a developmental- 
ly regulated manner. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Conditions for culturing of mouse C2C12 myoblast line and 
induction of myotube formation were essentially the same as 
described by Blau et al. [14]. Briefly, myoblasts were maintain- 
ed in an undifferentiated form in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 20% fetal bovine serum 
(Gibco) and 0.5% chicken embryo extract (Gibco). In order to 
induce myotube formation and fusion to multinucleated fibers, 
confluent cultures of myoblasts were cultured in DMEM and 
2% horse serum. 2-3 days were required to reach the formation 
of muscle fibers; the progress of the differentiation procedure 
was routinely followed by reverse phase microscopy. 
2.2. RNA preparation, electrophoresis and hybridization 
Total cellular RNA was isolated at different time points of 
the differentiation process according to the acid guanidium 
thiocyanate method of Chomczynski and Sacchi [15]. RNA 
samples (10 peg each) were denatured with formaldehyde, frac- 
tionated on 1.2% formaldehyde-agarose g l [16] and transfer- 
red onto Nytran membranes (Schleicher and Schuell) by 
capillary transfer, baked, prehybridized and hybridized accor- 
ding to the manufacturer’s protocol. Following hybridization 
with rabbit skeletal mtiscle voltage dependent calcium channel 
a, and (~1 subunit-specific probes, filters were washed with 0.5 
x SSPE and 0.1% SDS at 45°C for 1 h. For other probes 
washings were done at a stringency of 0.1 x SSPE and 0.1% 
SDS at 55°C. 
2.3, Probes and labeling of probes 
A 4.3 kb EcoRI/SacI and a 3.4 kb EcoRI fragment from 
VDCC (or and cys cDNA clones, respectively [17,18], were used 
as subunit-specific probes for skeletal muscle VDCC mRNAs. 
A 1.1 kb PstI fragment of rat ,&actin cDNA which hybridizes 
to the cytoplasmic p- and y-actin mRNAs as well as the muscle- 
specific cY-actin mRNA, was used to monitor muscle cell dif- 
ferentiation [2]. To monitor the amount of RNA loaded on the 
Northern blots, the RNA samples were quantitated by hybridiz- 
ing with a 30-mer synthetic oligodeoxynucleotide probe, com- 
plementary to the 18 S mouse ribosomal RNA. The probe was 
prepared with an automatic DNA synthesizer (Applied 
Biosystems). DNA probes were labeled by random priming 
(Pharmacia) according to the method of [19]. The oligodeox- 
ynucleotide probe was end-labeled with T4 polynucleotide 
kinase [20] and purified with an Elu-tip (Schleicher and Schuell) 
according to manufacturers protocol. 
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3. RESULTS AND DISCUSSION 
Cultures of proliferating C2C12 myoblasts were 
kept for 2 days in DME + 20% fetal bovine 
serum + 0.5% chicken embryo extract. When the 
cells reached about 90% confluence they were 
shifted to DME + 2% horse serum to induce the 
formation of differentiated myotubes. Myoblasts 
in control cultures were present as single, mono- 
nucleated cells, whereas myoblasts in differen- 
tiating medium started to fuse on day 1 and about 
90% of nuclei were in myotubes by days 3-4. 
To examine muscle-specific expression of VDCC 
LY~ and cyz subunits during differentiation, total 
cellular RNA was isolated and size-separated on 
denaturing formaldehyde-agarose gels. The RNA 
blots were hybridized with ai and CYZ specific 
cDNA probes. 
Fig.la shows that in control myoblasts the 
VDCC (~1 subunit specific mRNA is not expressed 
at all or the expression is below the level of detec- 
tion for this technique. When myoblasts start to 
fuse and form myotubes, the al mRNA is induced 
(at 36 h) and accumulates to high levels (20-fold in- 
duction) between 60 and 96 h of myotube differen- 
tiation. In contrast to ai expression, a barely 
detectable level of a2 mRNA was found in non- 
fused myoblasts, the amount increases upon 
myotube differentiation and reaches high levels 
(IO-fold induction) between 36 and 96 h of myo- 
tube differentiation (fig. lb). 
The myoblast differentiation process also was 
monitored by measuring the u-, ,& and y-actin 
gene transcripts with a cross-hybridizing fi-actin 
cDNA probe. The results are presented in fig.lc. 
The cytoplasmic P/y-actin mRNAs are prevalent 
in myoblasts and they were deinduced during dif- 
ferentiation, whereas a-actin transcripts are form- 
ed only after myotube formation begins. 
Moreover, the a-actin transcript is dominant in 
later stages of differentiation and in total RNA 
taken from mouse skeletal muscle tissue. 
To monitor the amount of RNA samples loaded 
onto each slot, the blots were hybridized with a 
30-mer oligonucleotide probe complementary to 
the 18 S mRNA (fig.ld). The results show similar 
levels of RNA for each sample analyzed. 
Results of this study demonstrate that mRNAs 
for LY~ and LYZ subunits of voltage-gated calcium 
channel are expressed in a developmental fashion 
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Fig. 1. Expression of skeletal muscle voltage-dependent calcium 
channel cyi and (~2 subunit mRNAs in myoblasts and differen- 
tiating myotubes of C2C12 cells. Lane 1: myoblasts at 48 h in 
growth medium; lanes 2-6: myotubes in differentiating 
medium at 12, 36, 60, 72 and 96 h, respectively; lane 7: mouse 
skeletal muscle RNA. Blots a and b were probed with rabbit 
skeletal muscle VDCC LYE and a2 subunit-specific cDNAs, 
respectively. The same blots were also hybridized with cross- 
hybridizing rat ,%actin probe (c) or with 18 S rRNA 
oligonucleotide probe (d). 
in differentiating C2C12 myogenic cells. The 
mRNA for VDCC CXI subunit is not detectable in 
undifferentiated myoblasts, but is induced 20-fold 
during the terminal differentiation process. How- 
ever, the non-committed myoblasts express a 
relatively low level of (YZ mRNA and upon dif- 
ferentiation the levels of this mRNA species were 
also increased. Thus, both of the (~1 and cz2 subunit 
mRNAs are coordinately induced during myocyte 
differentiation, albeit not to equimolar extents. 
Our data are consistent with 2 recent observa- 
tions [22,23]. Romey et al. [22] have demonstrated 
that the number of dihydropyridine binding sites 
are developmentally regulated in primary cultures 
of mouse skeletal muscle cells. Upon cessation of 
proliferation and during the fusion into myotubes 
they observed a dramatic increase in dihydropyri- 
dine binding sites, whereas the Kd value remained 
constant throughout the developmental process. 
Using immunochemical techniques, Morton et al. 
[23] have also shown that the expression of LYI and 
CQ subunits of dihydropyridine sensitive calcium 
channel are developmentally regulated. 
A crucial question in understanding how the dif- 
ferential pattern of expression of VDCC CYI and (~2 
mRNAs are established and regulated can be 
answered by identification of &acting regulatory 
elements and trans-acting factors of the VDCC @I 
and (~2 subunit genes. 
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